Lundbeck
HLUN-B.CO
#2505
Rank
C$8.16 B
Marketcap
$8.53
Share price
-0.93%
Change (1 day)
22.38%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

P/S ratio for Lundbeck (HLUN-B.CO)

P/S ratio as of November 2024 (TTM): 1.97

According to Lundbeck 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.77. At the end of 2024 the company had a P/S ratio of 1.81.

P/S ratio history for Lundbeck from 2010 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.8111.22%
20231.6215.97%
20221.40419.75%
20210.2693-19.85%
20200.3360-13.88%
20190.3901-5.42%
20180.4125-18.73%
20170.50758.49%
20160.467810.96%
20150.421688.57%
20140.2236-9.12%
20130.246064.77%
20120.1493-35.78%
20110.232522.05%
20100.1905